Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $61.66 USD
Change Today +0.10 / 0.16%
Volume 3.5M
TEVA On Other Exchanges
Symbol
Exchange
New York
Mexico
Tel Aviv
As of 8:04 PM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert Koremans M.D.

Chief Executive Officer of Global Specialty Medicines Group and President of Global Specialty Medicines Group, Teva Pharmaceutical Industries Limited
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

53--

Background*

Mr. Robert Koremans, also known as Rob, M.D. has been the Chief Executive Officer and President of Global Specialty Medicines Group at Teva Pharmaceutical Industries Limited since April 24, 2013. Mr. Koremans served as the Chief Executive Officer and President of Teva Europe at Teva Pharmaceutical Industries Limited since March 2012. He served as the Chairman and the Chief Executive Officer of Zentiva N.V. from July 1, 2010 to 2011 and its President from September 01, ...

Read Full Background

Corporate Headquarters*

5 Basel Street
Petach Tikva, -- 49131

Israel

Phone: 972 3 926 7267
Fax: 972 3 923 4050

Board Members Memberships*

2007-2009
Former Chief Executive Officer, Managing Director and director
2010-N/A
Chairman

Education*

MD 1988
Erasmus University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TEVA:US $61.66 USD +0.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Omar S. Ishrak Chairman and Chief Executive Officer
Medtronic plc
$1.5M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$2.0M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.1M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEVA PHARMACEUTICAL-SP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.